— Know what they know.
Not Investment Advice

DARE NASDAQ

Dare Bioscience, Inc.
1W: +8.7% 1M: +13.9% 3M: -59.5% YTD: -56.8% 1Y: -60.8% 3Y: -84.7% 5Y: -95.9%
$0.84
-0.01 (-0.96%)
 
Weekly Expected Move ±8.9%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 53 · $12.6M mcap · 14M float · 3.13% daily turnover · Short 62% of daily vol

📊 Key Metrics

TTM
$1M
Revenue
+7816.7% YoY
$-11M
Net Income
+40.9% YoY
$-12M
Free Cash Flow
+1.0% YoY
-70.6%
Gross Margin
-1582.5%
Op. Margin
-1590.4%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE165.3%
ROA-62.2%
ROIC136.8%

Valuation

P/E-1.1
P/B-22.4
EV/EBITDA-2.9

Leverage

Debt/Equity-12.08
Current Ratio0.99
Interest Cov.-25.6x

Quality Scores

Piotroski F3/9
Altman Z-12.87
Beneish M0.00

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms